Bellevue Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-301,103
| Closed | -$6.03M | – | 146 |
|
|
2025
Q1 | $6.03M | Sell |
301,103
-444,879
| -60% | -$8.91M | 0.14% | 81 |
|
|
2024
Q4 | $19.9M | Sell |
745,982
-516,048
| -41% | -$13.8M | 0.38% | 62 |
|
|
2024
Q3 | $36M | Buy |
1,262,030
+44,929
| +4% | +$1.28M | 0.58% | 51 |
|
|
2024
Q2 | $26.5M | Sell |
1,217,101
-2,984
| -0.2% | -$65K | 0.43% | 61 |
|
|
2024
Q1 | $27M | Sell |
1,220,085
-12,293
| -1% | -$272K | 0.41% | 69 |
|
|
2023
Q4 | $26.6M | Buy |
1,232,378
+4,347
| +0.4% | +$93.8K | 0.41% | 65 |
|
|
2023
Q3 | $20.7M | Buy |
1,228,031
+103,988
| +9% | +$1.76M | 0.33% | 73 |
|
|
2023
Q2 | $15.4M | Buy |
1,124,043
+175,165
| +18% | +$2.4M | 0.22% | 87 |
|
|
2023
Q1 | $21.6M | Buy |
948,878
+4,566
| +0.5% | +$104K | 0.31% | 76 |
|
|
2022
Q4 | $22.2M | Buy |
944,312
+2,441
| +0.3% | +$57.5K | 0.3% | 79 |
|
|
2022
Q3 | $24.6M | Buy |
941,871
+812
| +0.1% | +$21.2K | 0.35% | 75 |
|
|
2022
Q2 | $20.7M | Buy |
941,059
+333,445
| +55% | +$7.32M | 0.29% | 86 |
|
|
2022
Q1 | $27.3M | Buy |
+607,614
| New | +$27.3M | 0.32% | 85 |
|